Bone mineral density and vitamin D levels in patients with group a COPD

References

• Watanabe R, Inoue D. Secondary osteoporosis. Chronic obstructive pulmonary disease: COPD. Clin Calcium. 2018;28:1647–1652.
   PubMedGoogle Scholar
• Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J. 2003;22:64s–75s.
   Web of Science ®Google Scholar
• Biskobing DM. COPD and osteoporosis. Chest. 2002;121:609–620.
   PubMed Web of Science ®Google Scholar
• Jorgensen NR, Schwarz P, Holme I, et al. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med. 2007;101:177–185.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Caram LMO, Tanni SE, et al. The relationship between vitamin D status and exacerbation in COPD patients – a literatüre review. Respir Med. 2018;139:34–38.
   PubMed Web of Science ®Google Scholar
• Ryo O, Reiko W, Daisuke I. Osteoporosis associated with chronic obstructive pulmonary disease. J Bone Metab. 2016;23:111–120.
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report). Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. [Accessed March 15, 2018]
   Google Scholar
• Fidan F, Alkan M, Tosun A. Pandemic era: vitamin D deficiency and insuffciency. Türk Osteoporoz Dergisi. 2014;20:71–74.
   Google Scholar
• International Osteoporosis Foundation [Internet]. Nyon, Switzerland: [Cited 2019 Mar 1]. Available from: http://www.iofbonehealth.org/
   Google Scholar
• Inoue D, Watanabe R, Okazaki R. COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis. 2016;29:637–648.
   Web of Science ®Google Scholar
• Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporos Int. 2011;22:1845–1853.
   PubMed Web of Science ®Google Scholar
• Dam TT, Harrison S, Fink HA, et al. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int. 2010;21:1341–1349.
   PubMed Web of Science ®Google Scholar
• Regan EA, Radcliff TA, Henderson WG, et al. Improving hip fractures outcomes for COPD patients. COPD. 2013;10:11–19.
   PubMedGoogle Scholar
• Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int. 2001;68:259–270.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Chubachi S, Kameyama N, et al. Effects of long-term cigarette smoke exposure on bone metabolism, structure, and quality in a mouse model of emphysema. PLoS One. 2018;13:e0191611.
   PubMed Web of Science ®Google Scholar
• Fang MA, Frost PJ, Iida-Klein A, et al. Effects of nicotine on cellular function in UMR 106–01 osteoblast-like cells. Bone. 1991;12:283–286.
   PubMed Web of Science ®Google Scholar
• Ramp WK, Lenz LG, Galvin RJ. Nicotine inhibits collagen synthesis and alkaline phosphatase activity, but stimulates DNA synthesis in osteoblast-like cells. Proc Soc Exp Biol Med. 1991;197:36–43.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Chubachi S. Bone turnover and bone structure in clinical animal models of COPD. Clin Calcium. 2016;26:1413–1418.
   PubMedGoogle Scholar
• Majumdar SR, Villa-Roel C, Lyons KJ, et al. Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respir Med. 2010;104:260–266.
   PubMed Web of Science ®Google Scholar
• Bai P, Sun Y, Jin J, et al. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res. 2011;12:157.
   PubMed Web of Science ®Google Scholar
• Verberne LDM, Leemrijse CJ, Swinkels ICS, et al. Overweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice. NPJ Prim Care Respir Med. 2017;27:63.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L, Wouters EFM, Smeenk FWJM, et al. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34:209–210.
   PubMed Web of Science ®Google Scholar
• Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int. 1998;8:261–267.
   PubMed Web of Science ®Google Scholar
• Kjensli A, Falch JA, Ryg M, et al. High prevalence of vertebral deformities in COPD patients: relationship to disease severity. Eur Respir J. 2009;33:1018–1024.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L, van den Borne BE, Smeenk FW, et al. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res. 2011;26:561–568.
   PubMed Web of Science ®Google Scholar
• Dennison EM, Compston JE, Flahive J, et al. Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 2012;50:1288–1293.
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest. 2007;132:1599–1607.
   PubMed Web of Science ®Google Scholar
• Morden NE, Sullivan SD, Bartle B, et al. Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int. 2011;22:1855–1862.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Tanaka T, Aita K, et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2015;33:392–400.
   PubMed Web of Science ®Google Scholar
• Duckers MJ, Evans AJ, Frase W, et al. Low bone mineral density in men with chronic obstructive pulmonary disease. Respir Res. 2011;12:101.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930.
   PubMed Web of Science ®Google Scholar
• Brincat M, Gambin J, Brincat M, et al. The role of vitamin D in osteoporosis. Maturitas. 2015;80:329–332.
   PubMed Web of Science ®Google Scholar
• Romme EA, Rutten EP, Smeenk FW, et al. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med. 2013;45:91–96.
   PubMed Web of Science ®Google Scholar
• Fink JE, Hackney AC, Matsumoto M, et al. Mobility and biomechanical functions in the aging male: testosterone and the locomotive syndrome. Aging Male. 2018;29:1–8.
   Web of Science ®Google Scholar
• Zhu B, Zhu B, Xiao C, et al. Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1907–1916.
   PubMed Web of Science ®Google Scholar
• Janssens W, Decramer M, Mathieu C, et al. Vitamin D and chronic obstructive pulmonary disease: hype or reality? Lancet Respir Med. 2013;1:804–812.
   PubMed Web of Science ®Google Scholar
• Førli L, Halse J, Haug E, et al. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med. 2004;256:56–62.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L, Smeenk FW, van den Borne BE, et al. Progression of osteoporosis in patients with COPD: a 3-year follow up study. Respir Med. 2012;106:861–870.
   PubMed Web of Science ®Google Scholar
• Carson EL, Pourshahidi LK, Madigan SM, et al. Vitamin D status is associated with muscle strength and quality of life in patients with COPD: a seasonal prospective observation study. COPD. 2018;13:2613–2622.
   Google Scholar
• Nuti R, Siviero P, Maggi S, et al. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int. 2009;20:989–998.
   PubMed Web of Science ®Google Scholar
• Canguven O, El Ansari W, Yassin A. Vitamin D supplementation as a potential therapeutic mediator in asthma: does dose really matter? A critical review of the literature. Aging Male. 2018;29:1–8.
   Google Scholar